BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year

Entrada Therapeutics Inc -2.23%

Entrada Therapeutics Inc

TRDA

12.69

-2.23%

- Entrada Therapeutics Inc TRDA.O:

  • ENTRADA THERAPEUTICS INC - ON TRACK TO REPORT ELEVATE-44-201 COHORT 1 DATA IN Q2 2026, COHORT 2 DATA BY END OF YEAR

  • ENTRADA THERAPEUTICS INC - INTENDS TO OPEN EXPANSION COHORT LATER THIS YEAR IN ELEVATE-44-201 STUDY

Source text: ID:nGNX25yJ7q

Further company coverage: TRDA.O


Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via